John P Perentesis, MD, FAAP
College of Medicine - UC
John Perentesis, MD, FAAP, is a member of the Leukemia Research Program at the OSUCCC – James, where his research focuses on developing molecularly targeted therapies for pediatric and adolescent cancer.In particular, his work centers on complementary studies of leukemia biology and pharmacogenetics of childhood cancer therapy. He is also interested in the expansion of the zebrafish model system in oncology. His studies have contributed to the development of recombinant anticancer drugs and the identification of genes involved in cellular regulation. Dr. Perentesis has co-authored many articles in well-known publications, including Pediatric Blood & Cancer, Clinical Cancer Research, Cancer and Journal of Clinical Oncology.